Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective

被引：0
|
作者：
FitzGerald, J. Mark [1 ]
Arnetorp, Sofie [2 ]
Smare, Caitlin [3 ]
Gibson, Danny [4 ]
Coulton, Karen [5 ]
Hounsell, Kirsty [3 ]
Sadatsafavi, Mohsen [6 ]
机构：
[1] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC, Canada
[2] AstraZeneca, Gothenburg, Sweden
[3] PAREXEL Int, London, England
[4] AstraZeneca, Luton, Beds, England
[5] AstraZeneca, Cambridge, England
[6] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; Quality of life; Exacerbation;
D O I：
10.1183/13993003.congress-2019.PA1964
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1964
引用
收藏
页数：3
相关论文
共 23 条
  • [1] The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Golam, Sarowar
    Sadatsafavi, Mohsen
    [J]. RESPIRATORY MEDICINE, 2020, 171
  • [2] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Sadatsafavi, Mohsen
    FitzGerald, J. Mark
    O'Byrne, Paul M.
    Soliman, Mena
    Sriskandarajah, Niroshan
    Vicente, Colin
    Golam, Sarowar Muhammad
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01):
  • [3] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Mohsen Sadatsafavi
    J. Mark FitzGerald
    Paul M. O’Byrne
    Mena Soliman
    Niroshan Sriskandarajah
    Colin Vicente
    Sarowar Muhammad Golam
    [J]. Allergy, Asthma & Clinical Immunology, 17
  • [4] Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma
    Antonio Buendia, Jefferson
    Guerrero Patino, Diana
    Lucio Talamoni, Hernan
    [J]. PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3699 - 3705
  • [5] As-Needed Budesonide/Formoterol Similar to Maintenance Budesonide Plus SABA in Patients with Mild Asthma
    Ebell, Mark H.
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 100 (10) : 646 - 647
  • [6] As-needed budesonide-formoterol better controlled mild asthma vs terbutaline, but maintenance budesonide was better
    Stanbrook, Matthew B.
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 169 (06) : JC31 - JC31
  • [7] Severe Exacerbations and Inhaled Corticosteroid Load with As-Needed Budesonide/Formoterol vs Maintenance Budesonide in Mild Asthma
    Bateman, E.
    Reddel, H. K.
    O'Byrne, P. M.
    Barnes, P. J.
    Zhong, N.
    Keen, C.
    Jorup, C.
    Lamarca, R.
    Siwek-Posluszna, A.
    FitzGerald, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy
    Reddel, Helen Kathryn
    Brusselle, Guy
    Lamarca, Rosa
    Gustafson, Per
    Anderson, Gary P.
    Jorup, Carin
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07): : 2104 - 2114.e3
  • [9] Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
    Jefferson Antonio Buendía
    Diana Guerrero Patiño
    [J]. BMC Pulmonary Medicine, 21
  • [10] Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
123